MedTrace Logo

Effect of Digital Follow-up Supported Patient Education on Immunosuppressive Medication Adherence and Quality of Life After Liver Transplantation

NCT07728604 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 48

Last updated 2026-07-27

No results posted yet for this study

Summary

This randomized controlled study aimed to evaluate the effect of digital follow-up supported patient education on immunosuppressive medication adherence and quality of life in adult liver transplant recipients. Participants in both groups received standard discharge education. The intervention group additionally received structured digital follow-up messages for 12 weeks, while the control group received standard care only. Medication adherence and quality of life were assessed before and after the intervention using validated questionnaires.

Conditions

  • Liver Transplantation
  • Medication Adherence

Interventions

BEHAVIORAL

Digital Follow-up Supported Patient Education

Participants received standard discharge education followed by structured digital follow-up messages for 12 weeks to improve immunosuppressive medication adherence and quality of life.

OTHER

Standard Care

Participants received routine discharge education and standard follow-up care. No additional digital follow-up messages or educational reminders were provided during the study period.

Sponsors & Collaborators

  • Cansu Yıldız

    lead OTHER

Principal Investigators

  • Cansu Yıldız · İzmir Tınaztepe University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-01-23
Primary Completion
2026-06-20
Completion
2026-06-20

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07728604 on ClinicalTrials.gov